Skip to content

Core Laboratories CLB Asset write-downs

Asset write-downs at other companies

Schlumberger
 logo
Schlumberger SLB
$82.75M+104%

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$492.77M-9.3%
Enterprise value$637.8M-7.6%
P/E17×-1.4×
P/S0.9×-0.1×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's asset write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's asset write-downs?
Core Laboratories (CLB) reported asset write-downs of $180K in Q1 2026.
How has Core Laboratories's asset write-downs changed year-over-year?
Core Laboratories's asset write-downs increased by 429.4% year-over-year, from $34K to $180K.